# Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa

> **NCT01823822** · PHASE2,PHASE3 · COMPLETED · sponsor: **University Hospital, Geneva** · enrollment: 62 (actual)

## Conditions studied

- Anorexia Nervosa

## Interventions

- **DIETARY_SUPPLEMENT:** Oral protein supplement (Tested product)
- **DIETARY_SUPPLEMENT:** Iso-caloric supplement (Control product)

## Key facts

- **NCT ID:** NCT01823822
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-03
- **Final completion:** 2009-04
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2013-04-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01823822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01823822, "Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01823822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*